Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
Vasileios Papaliagkas
ResearcherPublications, citations & collaboration network
Vasileios Papaliagkas is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 97 works, 1,646 citations, an h-index of 21 and an i10-index of 34.
97
Works
1,646
Citations
21
h-index
34
i10-index
How has Vasileios Papaliagkas's publication output changed over time?
ScholarIQpublication output · 2008–2024
Output grew0% over the shown period — from 1 works in 2008 to 1 in 2024.
1
1
2
1
3
2
1
2008201020112020202220232024
What are the most-cited papers on Vasileios Papaliagkas?
ScholarIQmost cited works
Alzheimer’s Disease as Type 3 Diabetes: Common Pathophysiological Mechanisms between Alzheimer’s Disease and Type 2 Diabetes
Michail Michailidis, Despina Μoraitou, Despina Α. Tata, Kallirhoe Kalinderi, Theodora Papamitsou, Vasileios Papaliagkas
International Journal of Molecular Sciences. 2022320 CitationsOPEN ACCESS
Usefulness of event-related potentials in the assessment of mild cognitive impairment
Vasileios Papaliagkas, Vasilios Κ. Kimiskidis, Magda Tsolaki, G. Anogianakis
S82595977. 2008116 CitationsOPEN ACCESS
Cognitive event-related potentials: Longitudinal changes in mild cognitive impairment
Vasileios Papaliagkas, Vasilios Κ. Kimiskidis, Magda Tsolaki, G. Anogianakis
Clinical Neurophysiology. 201192 Citations
GLP-1 Receptor Agonists: A New Treatment in Parkinson’s Disease
Kallirhoe Kalinderi, Vasileios Papaliagkas, Liana Fidani
International Journal of Molecular Sciences. 202489 CitationsOPEN ACCESS
Antidiabetic Drugs in the Treatment of Alzheimer’s Disease
Michail Michailidis, Despina Α. Tata, Despina Μoraitou, Dimitrios Kavvadas, Sofia Karachrysafi, Theodora Papamitsou, Patroklos Vareltzis, Vasileios Papaliagkas
International Journal of Molecular Sciences. 202271 CitationsOPEN ACCESS
Related on ScholarIQ
International Hellenic University
Institution
Alzheimer’s Disease as Type 3 Diabetes: Common Pathophysiological Mechanisms between Alzheimer’s Disease and Type 2 Diabetes
Paper
Usefulness of event-related potentials in the assessment of mild cognitive impairment
Paper
Cognitive event-related potentials: Longitudinal changes in mild cognitive impairment
Paper
GLP-1 Receptor Agonists: A New Treatment in Parkinson’s Disease
Paper
Antidiabetic Drugs in the Treatment of Alzheimer’s Disease
Paper